BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19217656)

  • 1. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Becker G; Blum HE
    Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Neyens R; Jackson KC
    J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW
    Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond.
    Sinatra RS
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S16-23. PubMed ID: 16597531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
    Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
    Yuan CS; Israel RJ
    Expert Opin Investig Drugs; 2006 May; 15(5):541-52. PubMed ID: 16634692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user.
    Ladanyi A; Temkin SM; Moss J
    Int J Gynecol Cancer; 2010 Feb; 20(2):308-10. PubMed ID: 20134275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
    Saclarides TJ
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
    Holzer P
    Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction].
    Meerpohl JJ; Timmer A
    Z Gastroenterol; 2008 Sep; 46(9):917-21. PubMed ID: 18810678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor.
    DeHaven-Hudkins DL; DeHaven RN; Little PJ; Techner LM
    Pharmacol Ther; 2008 Jan; 117(1):162-87. PubMed ID: 18022696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
    Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
    Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects.
    Reichle FM; Conzen PF
    Curr Opin Investig Drugs; 2008 Jan; 9(1):90-100. PubMed ID: 18183536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
    Yuan CS
    Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of postoperative ileus.
    Thompson M; Magnuson B
    Orthopedics; 2012 Mar; 35(3):213-7. PubMed ID: 22385598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature.
    Schwenk ES; Grant AE; Torjman MC; McNulty SE; Baratta JL; Viscusi ER
    Reg Anesth Pain Med; 2017; 42(6):767-777. PubMed ID: 29016552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
    Kraft MD
    Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation.
    Lang L
    Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials.
    Yu CS; Chun HK; Stambler N; Carpenito J; Schulman S; Tzanis E; Randazzo B
    Dis Colon Rectum; 2011 May; 54(5):570-8. PubMed ID: 21471758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.